Dogwood Therapeutics, Inc. (DWTX)
2025-06-30 | ||||
|---|---|---|---|---|
| Interest income (expense), net | 111,379 | |||
| Exchange gain (loss), net | 4,532 | |||
| Total other income (expense) | 115,911 | |||
| Research and development | 2,569,943 | |||
| General and administrative expenses | 1,353,172 | |||
| Total operating expenses | 3,923,115 | |||
| Loss from operations | -3,923,115 | |||
| Loss before income taxes | -3,807,204 | |||
| Deferred income tax expense | 149 | |||
| Net loss | -3,807,353 | |||
| Net loss attributable to common stockholders | -3,807,353 | |||
| Earnings per share, basic | -1.99 | |||
| Earnings per share, diluted | -1.99 | |||
| Weighted average number of shares outstanding, basic | 1,911,128 | |||
| Weighted average number of shares outstanding, diluted | 1,911,128 | |||